Ischemic Stroke and Secondary Prevention in Clinical Practice | Zendy

Signild Åsberg | Zendy; Karin Henriksson | Zendy; Bahman Farahmand | Zendy; Kjell Asplund | Zendy; Bo Norrving | Zendy; Peter Appelros | Zendy; Birgitta Stegmayr | Zendy; Kerstin Hulter Åsberg | Zendy; Andreas Terént | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ischemic Stroke and Secondary Prevention in Clinical Practice

Author(s) -

Signild Åsberg,

Karin Henriksson,

Bahman Farahmand,

Kjell Asplund,

Bo Norrving,

Peter Appelros,

Birgitta Stegmayr,

Kerstin Hulter Åsberg,

Andreas Terént

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.580209

Subject(s) - medicine , hazard ratio , odds ratio , stroke (engine) , antiplatelet drug , angiotensin converting enzyme , medical prescription , diabetes mellitus , anticoagulant , proportional hazards model , atrial fibrillation , logistic regression , myocardial infarction , clopidogrel , confidence interval , pharmacology , endocrinology , blood pressure , mechanical engineering , engineering

Secondary prevention is recommended after stroke, but adherence to guidelines is unknown. We studied the prescription of antiplatelet drugs, angiotensin-converting enzyme inhibitors, statins, and anticoagulant drugs and their relation to risk of death.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research